Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Illumina Laboratory Services, |
RCV000320467 | SCV000358658 | uncertain significance | PGM1-congenital disorder of glycosylation | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000379588 | SCV000358659 | uncertain significance | Congenital disorder of glycosylation | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Invitae | RCV000320467 | SCV003291986 | uncertain significance | PGM1-congenital disorder of glycosylation | 2022-05-20 | criteria provided, single submitter | clinical testing | ClinVar contains an entry for this variant (Variation ID: 297889). This sequence change replaces alanine, which is neutral and non-polar, with threonine, which is neutral and polar, at codon 471 of the PGM1 protein (p.Ala471Thr). This variant is present in population databases (rs148979330, gnomAD 0.006%). This variant has not been reported in the literature in individuals affected with PGM1-related conditions. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |